3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
3
Hematologic Neoplasms
3
Adenocarcinoma of Lung
3
Cholangiocarcinoma
2
Thyroid Carcinoma, Anaplastic
1
Noonan Syndrome 6
1
Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
1
Neuroblastoma
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Granuloma, Plasma Cell
1
Glioblastoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma
1
Brain Neoplasms
1
Adenocarcinoma Of Esophagus
1
ALK-positive Non-small Cell Lung Cancer
1
Interventions
Cyclophosphamide
34
Etoposide
25
Doxorubicin
20
Carboplatin
20
Vincristine
19
Isotretinoin
19
Topotecan
17
Temozolomide
17
Irinotecan
16
Filgrastim
16
Melphalan
15
Cisplatin
15
sargramostim
14
Radiotherapy
14
Granulocyte-Macrophage Colony-Stimulating Factor
13
3-Iodobenzylguanidine
12
dinutuximab
11
Peripheral Blood Stem Cell Transplantation
11
naxitamab
9
Thiotepa
9
Magnetic Resonance Spectroscopy
9
humanized 3F8 anti-GD2 monoclonal antibody
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Ifosfamide
6
Antilymphocyte Serum
6
fludarabine phosphate
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neuroblastoma
×
ceritinib
×
Clear all
NCT02559778
2026-04-28
PEDS-PLAN
Milton S. Hershey Medical Center
Phase 2
Recruiting
500 enrolled